Why these ASX shares just stormed to 52-week highs

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price is one of three that just raced to 52-week highs or better…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries index was a strong performer on Tuesday, rising by a solid 0.8% to 6,853 points. This strong gain means the index is now trading close to its all-time high.

Unsurprisingly, this positive form means a number of shares are trading at 52-week highs or better. Here are three shares that have just reached this milestone:

The Codan Limited (ASX: CDA) share price was on form again on Tuesday and rose to a record high of $5.72. Investors have been buying the electronic products manufacturer's shares this year thanks to its impressive performance in FY 2019 and a sustained rise in the gold price. In FY 2019 Codan posted a 17.8% increase in sales to $271 million and a 15% lift in adjusted net profit of $46 million. A key driver of this growth was strong metal detector sales due to the rise in the gold price.

The Domain Holdings Australia Ltd (ASX: DHG) share price stormed to a 52-week high of $3.60 yesterday. Investors were scrambling to buy the property listings company's shares after the release of strong housing market data. According to property data provider CoreLogic, over the quarter ended September 30 Sydney and Melbourne house prices increased 3.5% and 3.4%, respectively. This appears to support the view that the housing market downturn has ended, which is likely to lead to an acceleration in listings volumes for Domain.

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price continued its positive run and hit a record-high of $3.03 on Tuesday. The biopharmaceutical company's shares have been on fire this week after it revealed a ground-breaking discovery for its drug designed to treat osteoarthritis in the knees. According to the release, the company's patented Zilosul drug has been shown to inhibit nerve growth factor in bone cells in knee osteoarthritis patients. Whilst there is still a long road ahead, things are looking very positive for the Zilosul drug and Paradigm right now.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Highs

Hands reaching high for a trophy with a sunset in the background.
52-Week Highs

4 ASX All Ords shares smashing new 52-week highs today

Do you own any of these lucky shares?

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
52-Week Highs

5 ASX All Ords shares starting the new year at 52-week highs

What a way to start 2025...

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
52-Week Highs

3 ASX 300 shares smashing new highs while the market dives

These three shares are running hot amid a market meltdown.

Read more »

Three hikers lift their arms in jubilation as they reach a rocky peak overlooking a sensational view of water and mountains with a blue sky surrounding them.
52-Week Highs

3 blue chip ASX 200 shares smashing new highs on Wednesday

These names are finishing the year strongly.

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
ETFs

10 red-hot ASX ETFs that smashed new highs today

Do you own any of these lucky exchange-traded funds?

Read more »

Two kids stare open-mouthed at what's under their bed.
52-Week Highs

5 under-the-radar ASX 200 shares smashing new highs today

These shares are bucking the market big time.

Read more »

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

10 ASX 200 shares smashing new highs while the market sinks

Do you own any of these market-defying stocks?

Read more »

A woman looks up at a plane flying in the sky with arms outstretched as the Flight Centre share price surges
Travel Shares

Why the Qantas share price can keep flying to new highs

Qantas shares' new record highs are forecast to be broken in 2025 by this top broker.

Read more »